» Articles » PMID: 24781082

Age-dependent Neurovascular Dysfunction and Damage in a Mouse Model of Cerebral Amyloid Angiopathy

Overview
Journal Stroke
Date 2014 May 1
PMID 24781082
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Accumulation of amyloid-β in cerebral blood vessels occurs in familial and sporadic forms of cerebral amyloid angiopathy and is a prominent feature of Alzheimer disease. However, the functional correlates of the vascular pathology induced by cerebral amyloid angiopathy and the mechanisms involved have not been fully established.

Methods: We used male transgenic mice expressing the Swedish, Iowa, and Dutch mutations of the amyloid precursor protein (Tg-SwDI) to examine the effect of cerebral amyloid angiopathy on cerebrovascular structure and function. Somatosensory cortex cerebral blood flow was monitored by laser-Doppler flowmetry in anesthetized Tg-SwDI mice and wild-type littermates equipped with a cranial window.

Results: Tg-SwDI mice exhibited reductions in cerebral blood flow responses to whisker stimulation, endothelium-dependent vasodilators, or hypercapnia at 3 months when compared with wild-type mice, whereas the response to adenosine was not attenuated. However, at 18 and 24 months, all cerebrovascular responses were markedly reduced. At this time, there was evidence of cerebrovascular amyloid deposition, smooth muscle fragmentation, and pericyte loss. Neocortical superfusion with the free radical scavenger manganic(I-II)meso-tetrakis(4-benzoic acid) porphyrin rescued endothelium-dependent responses and functional hyperemia completely at 3 months but only partially at 18 months.

Conclusions: Tg-SwDI mice exhibit a profound age-dependent cerebrovascular dysfunction, involving multiple regulatory mechanisms. Early in the disease process, oxidative stress is responsible for most of the vascular dysfunction, but with advancing disease structural alterations of the vasomotor apparatus also play a role. Early therapeutic interventions are likely to have the best chance to counteract the deleterious vascular effects of cerebral amyloid angiopathy.

Citing Articles

Reduction of orexin-expressing neurons and a unique sleep phenotype in the Tg-SwDI mouse model of Alzheimer's disease.

Wu Y, Bhat N, Liu M Front Aging Neurosci. 2025; 17:1529769.

PMID: 39968126 PMC: 11832706. DOI: 10.3389/fnagi.2025.1529769.


Inhibition of IFITM3 in cerebrovascular endothelium alleviates Alzheimer's-related phenotypes.

Feng Y, Wang S, Yang D, Zheng W, Xia H, Zhu Q Alzheimers Dement. 2025; 21(2):e14543.

PMID: 39807629 PMC: 11851164. DOI: 10.1002/alz.14543.


The cerebral blood flow response to neuroactivation is reduced in cognitively normal men with β-amyloid accumulation.

Vestergaard M, Bakhtiari A, Osler M, Mortensen E, Lindberg U, Law I Alzheimers Res Ther. 2025; 17(1):4.

PMID: 39754275 PMC: 11699738. DOI: 10.1186/s13195-024-01652-z.


Vascular Function and Ion Channels in Alzheimer's Disease.

Taylor J, Martin-Aragon Baudel M, Nieves-Cintron M, Navedo M Microcirculation. 2024; 31(7):e12881.

PMID: 39190776 PMC: 11498901. DOI: 10.1111/micc.12881.


Molecular hydrogen supplementation in mice ameliorates lipopolysaccharide-induced loss of interest.

Koga M, Sato M, Nakagawa R, Tokuno S, Asai F, Maezawa Y PCN Rep. 2024; 3(3):e70000.

PMID: 39171191 PMC: 11337204. DOI: 10.1002/pcn5.70000.


References
1.
Braak H, Braak E . Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991; 82(4):239-59. DOI: 10.1007/BF00308809. View

2.
Park L, Zhou P, Koizumi K, El Jamal S, Previti M, Van Nostrand W . Brain and circulating levels of Aβ1-40 differentially contribute to vasomotor dysfunction in the mouse brain. Stroke. 2012; 44(1):198-204. PMC: 3530010. DOI: 10.1161/STROKEAHA.112.670976. View

3.
Park L, Zhou J, Zhou P, Pistick R, El Jamal S, Younkin L . Innate immunity receptor CD36 promotes cerebral amyloid angiopathy. Proc Natl Acad Sci U S A. 2013; 110(8):3089-94. PMC: 3581946. DOI: 10.1073/pnas.1300021110. View

4.
Charidimou A, Gang Q, Werring D . Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry. 2011; 83(2):124-37. DOI: 10.1136/jnnp-2011-301308. View

5.
Iadecola C . Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci. 2004; 5(5):347-60. DOI: 10.1038/nrn1387. View